Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety Study of DS-1040b in Thrombectomy-Treated Acute Ischemic Stroke
jRCT2080223556Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of DS1040b in ischemic stroke (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Safety and tolerability of DS-1040b. Started Jun 2017; status: completed.
02
Drugs
DS1040b
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2080223556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223556.